These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22525631)

  • 41. Hyperuricemia and gout.
    Lioté F
    Curr Rheumatol Rep; 2003 Jun; 5(3):227-34. PubMed ID: 12744816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Febuxostat for prevention of gout attacks.
    Pohar S; Murphy G
    Issues Emerg Health Technol; 2006 Aug; (87):1-4. PubMed ID: 16958189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and management of gout.
    Pittman JR; Bross MH
    Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term remission from gout associated with fenofibrate therapy.
    Hepburn AL; Kaye SA; Feher MD
    Clin Rheumatol; 2003 Feb; 22(1):73-6. PubMed ID: 12605325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hyperuricemia in hypertension: any clinical implication?].
    Deléaval P; Burnier M
    Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
    Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M
    Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of gout.
    Schlesinger N
    Minerva Med; 2007 Dec; 98(6):759-67. PubMed ID: 18299687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of gout: clinical, laboratory, and radiologic findings.
    Schlesinger N
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S443-50; quiz S465-8. PubMed ID: 16300458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Idiopathic hyperuricemia with overproduction of uric acid].
    Mizuta E; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent advances in the pathophysiology of hyperuricemia and gout].
    So A
    Rev Med Suisse; 2007 Mar; 3(103):720, 722-4. PubMed ID: 17458149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating to target: a strategy to cure gout.
    Perez-Ruiz F
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii9-ii14. PubMed ID: 19447780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis, clinical findings and management of acute and chronic gout.
    Corrado A; D'Onofrio F; Santoro N; Melillo N; Cantatore FP
    Minerva Med; 2006 Dec; 97(6):495-509. PubMed ID: 17213786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.
    Takahashi S; Moriwaki Y; Yamamoto T; Tsutsumi Z; Ka T; Fukuchi M
    Ann Rheum Dis; 2003 Jun; 62(6):572-5. PubMed ID: 12759298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets.
    Punzi L; Scanu A; Ramonda R; Oliviero F
    Autoimmun Rev; 2012 Nov; 12(1):66-71. PubMed ID: 22884557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.